Toronto Dominion Bank’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.26M Buy
17,954
+2,746
+18% +$345K ﹤0.01% 787
2025
Q1
$1.68M Buy
15,208
+2,025
+15% +$224K ﹤0.01% 788
2024
Q4
$1.8M Buy
13,183
+499
+4% +$68.1K ﹤0.01% 766
2024
Q3
$1.46M Buy
12,684
+3,131
+33% +$361K ﹤0.01% 695
2024
Q2
$1.32M Sell
9,553
-410
-4% -$56.4K ﹤0.01% 737
2024
Q1
$1.37M Sell
9,963
-3,329
-25% -$459K ﹤0.01% 734
2023
Q4
$1.75M Sell
13,292
-19,446
-59% -$2.56M ﹤0.01% 752
2023
Q3
$3.68M Sell
32,738
-4,794
-13% -$539K 0.01% 655
2023
Q2
$3.54M Buy
37,532
+10,015
+36% +$944K 0.01% 674
2023
Q1
$2.78M Sell
27,517
-1,310
-5% -$132K ﹤0.01% 704
2022
Q4
$3.44M Buy
28,827
+7,885
+38% +$941K 0.01% 642
2022
Q3
$2.22M Sell
20,942
-307
-1% -$32.6K ﹤0.01% 703
2022
Q2
$2.07M Buy
21,249
+938
+5% +$91.4K ﹤0.01% 741
2022
Q1
$1.9M Sell
20,311
-33,350
-62% -$3.13M ﹤0.01% 793
2021
Q4
$4.57M Buy
53,661
+40,310
+302% +$3.43M 0.01% 648
2021
Q3
$1.28M Sell
13,351
-85
-0.6% -$8.16K ﹤0.01% 849
2021
Q2
$1.31M Buy
13,436
+1,441
+12% +$140K ﹤0.01% 829
2021
Q1
$1.17M Sell
11,995
-4,686
-28% -$456K ﹤0.01% 833
2020
Q4
$1.6M Buy
16,681
+1,916
+13% +$184K ﹤0.01% 805
2020
Q3
$1.42M Buy
14,765
+1,416
+11% +$136K ﹤0.01% 766
2020
Q2
$1.63M Buy
13,349
+1,411
+12% +$172K ﹤0.01% 731
2020
Q1
$1.03M Sell
11,938
-3,293
-22% -$285K ﹤0.01% 724
2019
Q4
$1.64M Buy
+15,231
New +$1.64M ﹤0.01% 701
2019
Q1
Sell
-13
Closed -$1K 1211
2018
Q4
$1K Buy
13
+8
+160% +$615 ﹤0.01% 1066
2018
Q3
$1K Sell
5
-7,585
-100% -$1.52M ﹤0.01% 1038
2018
Q2
$746K Buy
7,590
+7,560
+25,200% +$743K ﹤0.01% 726
2018
Q1
$2K Buy
+30
New +$2K ﹤0.01% 973